DexCom Inc. DXCM recently announced that its G7 Continuous Glucose Monitoring (CGM) System will be added to the Régie de l'assurance maladie du Québec (RAMQ) Public Prescription Drug Insurance Plan.

the Dexcom G7 (more on this later). Having used a total of five different CGMs, I’ve noticed the key information that matters to long-term diabetes care, and while the Dexcom Stelo — and ...

Matthew Taylor, an analyst from Jefferies, reiterated the Buy rating on Dexcom (DXCM – Research Report ... and the upcoming launch of its 15-day G7 system, offer promising growth opportunities.